Skip to content
Home/Companies/HealthTech/NeuroNation
NeuroNation

NeuroNation

HealthTech·Germany·Exited 2026·Held 6yr
Entry
2020
Hold
6yr
Exit
2026

Who owns NeuroNation?

NeuroNation is a German HealthTech company, now owned by Schwabe Group, which acquired it in 2026 from Impact Partners.

Hand-verified · updated 2026-06-06

Open JSON · CC-BY
Impact Partners
Investor
Impact Partners
Impact Partners Social · 2015 · Impact

Key facts

HQGermany
SectorHealthTech
StatusActive
Websitewww.neuronation.com
Exit Type
Trade Sale
Buyer
Schwabe Group
Exit Year
2026

More from Impact Partners Social

Other portfolio companies in the same fund.

Foorban
Active
Italy· 2026
FYLD
Active
AI/MLUnited Kingdom· 2026
Groupe Medimex
Active
HealthcareFrance· 2026
Carelink Gruppen
Active
HealthcareDenmark· 2025
Grupo Aire Limpio
Grupo Aire Limpio
Active
ConstructionSpain· 2025
Tekman Education
Tekman Education
Active
EducationSpain· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns NeuroNation?

NeuroNation is now owned by Schwabe Group, which acquired it in 2026 from Impact Partners.

When did Schwabe Group acquire NeuroNation?

Schwabe Group acquired NeuroNation in 2026, buying from Impact Partners.

Who did NeuroNation sell to?

Impact Partners sold NeuroNation to Schwabe Group in 2026 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue